Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001651844-18-000007)

Filing Details

Accession Number:: 0001651844-18-000007
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-02-13 09:45:44
Reporting Period:: 2018-02-12

Accepted Time:: 2018-02-13 09:45:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1018735	Nymox Pharmaceutical Corp	NYMX	In Vitro & In Vivo Diagnostic Substances (2835)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1651844	George James Robinson	10 East Lee Street Suite 2705 Baltimore MD 21202		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-02-12	300	$3.25	3,107,850	No	4	P	Direct
Common Stock	Acquisiton	2018-02-12	5,600	$3.25	3,113,450	No	4	P	Direct
Common Stock	Acquisiton	2018-02-12	100	$3.26	3,113,550	No	4	P	Direct
Common Stock	Acquisiton	2018-02-12	100	$3.28	3,113,650	No	4	P	Direct
Common Stock	Acquisiton	2018-02-12	100	$3.29	3,113,750	No	4	P	Direct
Common Stock	Acquisiton	2018-02-12	200	$3.30	3,113,950	No	4	P	Direct
Common Stock	Acquisiton	2018-02-12	100	$3.31	3,114,050	No	4	P	Direct
Common Stock	Acquisiton	2018-02-12	500	$3.32	3,114,550	No	4	P	Direct
Common Stock	Acquisiton	2018-02-12	1,000	$3.33	3,115,550	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct